Thrombophilia testing revealed homozygosity for the plasminogen activator inhibitor-1 (PAI-1) 4G/4G mutation, which is known to confer a prothrombotic phenotype. This evidence concerns the gene SERPINE1 and Rare hereditary thrombophilia.